IRIS
BURIONI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.993
NA - Nord America 2.205
EU - Europa 1.853
SA - Sud America 920
AF - Africa 65
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.108
SG - Singapore 1.271
CN - Cina 820
BR - Brasile 757
SE - Svezia 634
IT - Italia 534
HK - Hong Kong 421
VN - Vietnam 251
RU - Federazione Russa 172
DE - Germania 136
GB - Regno Unito 74
AR - Argentina 73
FI - Finlandia 70
NL - Olanda 52
CA - Canada 49
IN - India 49
PL - Polonia 35
EC - Ecuador 32
MX - Messico 31
FR - Francia 30
ZA - Sudafrica 29
ID - Indonesia 28
AT - Austria 26
BD - Bangladesh 26
ES - Italia 22
IE - Irlanda 22
CO - Colombia 20
JP - Giappone 20
IQ - Iraq 18
TR - Turchia 15
PY - Paraguay 14
RO - Romania 11
UZ - Uzbekistan 11
PK - Pakistan 10
LT - Lituania 9
SA - Arabia Saudita 9
AU - Australia 7
EG - Egitto 7
MA - Marocco 7
TN - Tunisia 7
UA - Ucraina 7
CL - Cile 6
IR - Iran 6
UY - Uruguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KE - Kenya 4
NP - Nepal 4
PE - Perù 4
AZ - Azerbaigian 3
BH - Bahrain 3
DZ - Algeria 3
GA - Gabon 3
JO - Giordania 3
KZ - Kazakistan 3
TT - Trinidad e Tobago 3
BE - Belgio 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GE - Georgia 2
IL - Israele 2
IS - Islanda 2
KW - Kuwait 2
NI - Nicaragua 2
PH - Filippine 2
RS - Serbia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ME - Montenegro 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TL - Timor Orientale 1
TZ - Tanzania 1
Totale 8.045
Salva come PNG Salva come JPEG
Città #
Dallas 646
Singapore 515
Hong Kong 418
Ashburn 260
Shanghai 236
Hefei 179
Princeton 171
Lawrence 168
Beijing 124
Milan 119
New York 94
Ho Chi Minh City 91
São Paulo 69
Moscow 65
Los Angeles 63
Hanoi 55
Helsinki 53
Munich 33
Rome 31
Warsaw 31
Bologna 29
London 26
Nuremberg 26
Montreal 23
Rio de Janeiro 23
Dublin 22
Santa Clara 22
Ancona 21
Boardman 20
Brasília 19
Johannesburg 19
Stockholm 19
Orem 18
Tokyo 18
Chennai 17
Council Bluffs 16
Poplar 16
Biên Hòa 14
Boston 14
Chicago 14
Seattle 14
Toronto 14
Belo Horizonte 13
Amsterdam 12
Atlanta 12
Brescia 12
Brooklyn 12
Denver 12
Falkenstein 12
Houston 12
Mexico City 12
Quito 12
Shenzhen 12
Turin 12
Turku 12
Da Nang 11
Guangzhou 11
Pune 11
Tianjin 11
Curitiba 10
Guayaquil 10
Tashkent 10
Vienna 10
Washington 10
Guarulhos 9
Santo André 9
Sorocaba 9
Ankara 8
Manaus 8
Manchester 8
Marino 8
Ninh Bình 8
Porto Alegre 8
Salvador 8
San Francisco 8
Asunción 7
Frankfurt am Main 7
Hangzhou 7
Jeddah 7
Phoenix 7
Verona 7
Campinas 6
Cape Town 6
Columbus 6
Contagem 6
Duhok 6
Jiaxing 6
Pelotas 6
Querétaro 6
San Jose 6
The Dalles 6
Boca 5
Bogotá 5
Borås 5
Buenos Aires 5
Cairo 5
Catania 5
Cesano Boscone 5
Changsha 5
City of London 5
Totale 4.334
Salva come PNG Salva come JPEG
Nome #
Salute : Le frontiere della medicina : Volumi dedicati alla Salute a cura di Roberto Burioni 212
Virus, la grande sfida : dal coronavirus alla peste : come la scienza può salvare l'umanità / Roberto Burioni ; con la collaborazione di Pier Luigi Lopalco 200
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 149
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 96
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 91
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 90
A Biologically-validated HCV E1E2 Heterodimer Structural Model 86
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 85
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 83
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 77
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 76
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 75
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 75
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 75
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 72
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 72
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 72
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 70
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 70
Match point. Come la scienza sta sconfiggendo il cancro 68
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 68
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 67
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 67
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 66
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 66
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 65
A closer look at prion strains: Characterization and important implications 65
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 65
Bacteriophages and Their Immunological Applications against Infectious Threats 65
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 64
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 64
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 63
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 63
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 62
63. Vaccini Antivirali 60
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 60
A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes 59
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 59
"Freezing" parasites in pre-Himalayan region, Himachal Pradesh: Experience with mini-FLOTAC 59
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 58
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 58
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 57
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 57
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 56
66. Vaccini antivirali 56
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 56
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 56
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 55
36. Meccanismi difensivi dell'ospite alle infezioni virali 53
Role and potential therapeutic use of antibodies against herpetic infections 53
Major sports events and the transmission of sars-cov-2: Analysis of seven case-studies in europe 53
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes 52
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 51
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 51
A NEW PLASMID CLONING VECTOR FOR DIRECT-DETECTION OF RECOMBINANT CLONES, BASED ON INACTIVATION OF A BACTERIAL ACID PHOSPHATASE-ENCODING GENE 51
Assessing the human immune response to SARS-CoV-2 variants 51
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 49
A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries 49
HCV E2 core structures and mAbs: something is still missing 49
39 Meccanismi difensivi dell'ospite alle infezioni virali 47
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 47
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 46
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 46
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 46
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases? 45
Method for the preparation of new oligoclonal antibodies 45
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 44
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 44
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 44
Phage display for the production of human monoclonal antibodies against human pathogens 44
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 44
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 43
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 43
Has SARS-CoV-2 reached peak fitness? 43
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 42
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 42
Blocking immunodominant epitopes by competitive deselection. 42
Phage Display Technology 41
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections 41
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 41
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library 40
Risks of "blind" automated identification systems in medical microbiology 40
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 40
Humoral immune response against hepatitis C virus 39
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 39
Human Monoclonal Antibody Fab Fragments directed against HCV E2 glycoprotein and endowed with neutralizing activity 38
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 38
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab 38
Correspondence: Italy's policy shift on immunization 38
Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects 38
Title: Acute respiratory distress in a neutropenic febrile patient after Hematopoietic Cell Transplantation 37
Anticorpo monoclonale diretto contro il virus JC 37
Il vaccino non è un'opinione. Le vaccinazioni spiegate a chi proprio non le vuole capire 37
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction 37
Natalizumab-Associated Progressive Multifocal Leukoencephalopathy 37
Evaluation of resistance against bacterial microleakage of a new conical implant-abutment connection versus conventional connections: an in vitro study. 36
Molecular Diagnosis of Scedosporium apiospermum Keratitis. 36
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV) 36
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 36
Omeopatia : bugie, leggende e verità 36
Totale 5.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 1 1 0 0 1 0 0
2021/2022142 0 0 7 41 6 3 17 14 6 27 7 14
2022/20231.104 387 281 95 11 11 135 48 56 55 3 14 8
2023/2024530 24 38 79 62 29 100 11 43 4 38 19 83
2024/20252.405 292 34 45 131 72 225 354 217 430 273 154 178
2025/20263.879 608 629 805 1.149 526 162 0 0 0 0 0 0
Totale 8.205